XLVvsJDOCETF Comparison
VS
State Street Health Care Select Sector SPDR ETF (XLV) belongs to the US Health Care segment. JPMorgan Healthcare Leaders ETF (JDOC) is part of the Global Blended Cap segment. Both ETFs have the same top 3 sector exposures: Healthcare and Consumer Non-Cyclicals. XLV is less expensive with a Total Expense Ratio (TER) of 0.08%, versus 0.65% for JDOC. XLV is up 5.91% year-to-date (YTD) with +$963M in YTD flows. JDOC performs worse with 5.17% YTD performance, and -$34K in YTD flows. Run a side-by-side ETF comparison of XLV and JDOC below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
XLV vs JDOC performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 07/24/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | XLV JDOC | +6.02%+4.47% | +13.21%+10.58% | +5.91%+5.17% | +21.88%+20.45% | +25.71%n/a | +34.93%n/a |
| Flows | XLV JDOC | +$1.43B- | -$177M-$3M | +$963M-$34K | +$2.15B-$34K | -$5.26B- | +$3.47B- |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | XLV JDOC | +18.26%+17.36% | +15.69%+14.97% | +14.32%n/a | +14.97%n/a |
| Max drawdown | XLV JDOC | -3.83%-3.99% | -10.51%-9.66% | -17.05%n/a | -17.05%n/a |
| Max drawdown duration | XLV JDOC | 17d19d | 116d154d | 444dn/a | 444dn/a |
Trading data
XLV | JDOC | |
Last sale 7/27/2026 at 2:26 PM | $164.07 | $60.80 |
| Previous close 07/24/2026 | $162.57 | $60.60 |
| Consolidated volume 07/24/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of June 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
JDOC
is actively managed and doesn’t replicate an indexXLV | JDOC | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 7/27/2026 at 2:26 PM
Live
Closed
XLV | JDOC | |
|---|---|---|
| Last price | $164.07 | $60.80 |
| 1D performance | +0.92% | +0.32% |
| AuM | $42.54 B | $9.13 M |
| E/R | 0.08% | 0.65% |
Characteristics
XLV | JDOC | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | State Street Investment Management | J.P. Morgan Asset Management |
| Benchmark | S&P Health Care Select Sector Index | - |
| N° of holdings | 59 | 61 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | December 16, 1998 | November 1, 2023 |
| ESG | No | No |
Advertisement
Exposure
Countries
XLV
USA
97.92%
Other
2.08%
JDOC
USA
75.5%
Other
24.5%
Sectors
XLV
Healthcare
97.73%
Other
2.27%
JDOC
Healthcare
96.8%
Other
3.2%
Advertisement
Diversification
XLV
Total weight of top 15 holdings out of 15
72.82%
JDOC
Total weight of top 15 holdings out of 15
60.84%
Top 15 holdings
Data as of June 30, 2026
XLV
Eli Lilly & Co.
16.57%
Johnson & Johnson
10.68%
AbbVie, Inc.
7.76%
UnitedHealth Group, Inc.
6.59%
Merck & Co., Inc.
5.54%
Amgen, Inc.
3.41%
Thermo Fisher Scientific, Inc.
3.25%
Abbott Laboratories
2.76%
Gilead Sciences, Inc.
2.74%
Intuitive Surgical, Inc.
2.46%
Pfizer Inc.
2.40%
CVS Health Corp.
2.31%
Vertex Pharmaceuticals, Inc.
2.20%
Danaher Corp.
2.10%
Bristol Myers Squibb Co.
2.05%
JDOC
Eli Lilly & Co.
7.79%
AbbVie, Inc.
7.78%
UnitedHealth Group, Inc.
6.36%
Johnson & Johnson
4.83%
Merck & Co., Inc.
4.75%
AstraZeneca PLC
4.18%
Thermo Fisher Scientific, Inc.
3.36%
CVS Health Corp.
3.20%
Bristol Myers Squibb Co.
3.10%
Abbott Laboratories
2.81%
Roche Holding AG
2.73%
Novo Nordisk A/S
2.69%
GSK Plc
2.52%
argenx SE
2.50%
Intuitive Surgical, Inc.
2.24%
Frequently asked questions about XLV and JDOC
How have the XLV and JDOC ETFs performed in 2026?
As of July 24, 2026, XLV is up 5.91% year-to-date (YTD), while JDOC has returned 5.17%. That puts XLV better performer ahead so far this year.
Which ETF is attracting more investor money: XLV or JDOC?
Year-to-date, the XLV ETF saw +$963M in flows, compared to -$34K for JDOC.
Which ETF is more volatile: XLV or JDOC?
Over the past year, XLV had a volatility of 15.69%, while JDOC experienced 14.97%.
Which ETF is bigger: XLV or JDOC?
As of July 24, 2026, XLV holds $42.54 B in assets under management (AUM), while JDOC manages $9.13 M.
What sectors do the XLV and JDOC ETFs invest in?
XLV leans toward sectors like Healthcare. Meanwhile, JDOC focuses on Healthcare.
What are the top holdings of the XLV ETF and JDOC ETF?
XLV top holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc.. JDOC holds in its top three: Eli Lilly & Co., AbbVie, Inc. and UnitedHealth Group, Inc..
Which ETF is more diversified: XLV or JDOC?
XLV holds 59 securities with 72.82% of its assets in the top 15. JDOC has 61 securities and a top 15 weight of 60.84%.
Advertisement
Latest news about XLV & JDOC
ETF Model Portfolios: The Cockroach Portfolio
March 20, 2026
XLV
ETF Central's Guide to Defensive Sector Investing
March 13, 2026
XLV
Chinese Artificial Intelligence (AI) DeepSeek: ETF Winners & Losers
January 27, 2025
XLV
Investing in Sector ETFs: Consumer Staples, Healthcare, & Utilities
August 21, 2024
XLV
Advertisement
Healthcare Stocks Drop on Medicare Payment Rate Surprise
April 8, 2024
XLV
Healthcare Stocks Drop on Medicare Payment Rate Surprise
April 8, 2024
XLV
Advertisement
